AI assistant
CITIGROUP INC — Capital/Financing Update 2011
Nov 28, 2011
14792_rns_2011-11-28_048faf97-d247-447e-b30e-0e5060f6e807.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
Pricing Sheet No. 2011-MTNDG0156 dated November 23, 2011 relating to Offering Summary No. 2011-MTNDG0156 dated November 22, 2011 Registration Statement Nos. 333-172554 and 333-172554-01 Filed pursuant to Rule 433
STRUCTURED INVESTMENTS
Opportunities in U.S. Equities
308,000 PLUS Based on the Value of the S&P 500 ® Index due December 5, 2012
Performance Leveraged Upside Securities SM
| PRICING TERMS – NOVEMBER 23, 2011 — Issuer: | Citigroup Funding Inc. | ||
|---|---|---|---|
| Guarantee: | Any payments due on the PLUS are fully and unconditionally guaranteed by Citigroup Inc., Citigroup Funding Inc.’s parent company; however, because the PLUS are not principal protected, you may receive an amount at maturity that is substantially less than the stated principal amount of the PLUS and could be zero. | ||
| Aggregate principal amount: | $3,080,000 | ||
| Stated principal amount: | $10 per PLUS | ||
| Issue price: | $10 per PLUS (see “Underwriting fee and issue price” below) | ||
| Pricing date: | November 23, 2011 | ||
| Original issue date: | November 29, 2011 | ||
| Maturity date: | December 5, 2012 | ||
| Underlying index: | S&P 500 ® Index | ||
| Payment at maturity: | If the final index value is greater than the initial index value, • $10 + leveraged upside payment In no event will the payment at maturity exceed the maximum payment at maturity. If the final index value is less than or equal to the initial index value, • $10 x index performance factor This amount will be less than or equal to the stated principal amount of $10 and could be zero. There is no minimum payment at maturity on the PLUS. | ||
| Maximum payment at maturity: | $11.545 per PLUS (115.45% of the stated principal amount) | ||
| Leveraged upside payment: | $10 x leverage factor x index percent increase | ||
| Leverage factor: | 300% | ||
| Index percent increase: | (final index value - initial index value) / initial index value | ||
| Index performance factor: | final index value / initial index value | ||
| Initial index value: | 1,161.79, the closing value of the underlying index on the pricing date | ||
| Final index value: | The closing value of the underlying index on the valuation date | ||
| Valuation date: | November 30, 2012, subject to postponement for non-underlying asset business days and certain market disruption events | ||
| CUSIP: | 17317U394 | ||
| ISIN: | US17317U3941 | ||
| Listing: | The PLUS will not be listed on any securities exchange. | ||
| Underwriter: | Citigroup Global Markets Inc., an affiliate of the issuer, acting as principal. See “Fact Sheet—Supplemental information regarding plan of distribution; conflicts of interest” in the related offering summary. | ||
| Underwriting fee and issue price: | Price to public | Underwriting fee (1) | Proceeds to issuer |
| Per PLUS | $10.00 | $0.20 | $9.80 |
| Total | $3,080,000 | $61,600 | $3,018,400 |
(1) Citigroup Global Markets Inc., an affiliate of Citigroup Funding Inc. and the underwriter of the sale of the PLUS, will receive an underwriting fee of $0.20 from Citigroup Funding Inc. for each PLUS sold in this offering. From this underwriting fee, Citigroup Global Markets Inc. will pay selected dealers, including its affiliate Morgan Stanley Smith Barney LLC, and their financial advisors collectively a fixed selling concession of $0.20 for each PLUS they sell. Additionally, it is possible that Citigroup Global Markets Inc. and its affiliates may profit from expected hedging activity related to this offering, even if the value of the PLUS declines. You should refer to “Risk Factors” and “Fact Sheet—Supplemental information regarding plan of distribution; conflicts of interest” in the related offering summary for more information.
You should read this document together with the offering summary describing the offering and the
PLUS product supplement, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below.
Offering Summary filed on November 22, 2011:
EFPlaceholder http://www.sec.gov/Archives/edgar/data/1318281/000095010311004910/dp27386_fwp-0156.htm
PLUS Product Supplement filed on May 16, 2011:
EFPlaceholder http://www.sec.gov/Archives/edgar/data/831001/000119312511141342/d424b2.htm
Prospectus and Prospectus Supplement filed on May 12, 2011:
EFPlaceholder http://www.sec.gov/Archives/edgar/data/831001/000095012311049309/y91273b2e424b2.htm
The PLUS are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or
any other governmental agency, nor are they obligations of, or guaranteed by, a bank.
“Standard & Poor’s®,” “S&P®,” “S&P 500®,” “Standard & Poor’s 500” and “500” are trademarks of The McGraw-Hill Companies, Inc. and have been licensed for use by Citigroup Funding Inc. and its affiliates. The PLUS are not sponsored, endorsed, sold or promoted by Standard & Poor’s or The McGraw-Hill Companies and neither makes any representation or warranty regarding the advisability of investing in the PLUS.
Citigroup Funding Inc., the issuer, and Citigroup Inc., the guarantor, have filed a registration statement (including a PLUS product supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission (“Commission”) for the offering to which this communication relates. You should read the PLUS product supplement, prospectus supplement and prospectus in that registration statement (File No. 333-172554) and the other documents Citigroup Funding Inc. and Citigroup Inc. have filed with the Commission for more complete information about Citigroup Funding Inc., Citigroup Inc. and this offering. You may get these documents for free by visiting EDGAR on the Commission’s website at www.sec.gov. Alternatively, you can request the PLUS product supplement and related prospectus supplement and prospectus by calling toll-free 1-877-858-5407.